Biomarkers and Imaging Markers for ICH

Recruiting now

Conditions studied: Intracerebral Hemorrhage

In brief

Intracerebral hemorrhage (ICH) is a subtype of stroke associated with high mortality and disability. Basic and clinical research has contributed to our understanding of the complex pathophysiology in ICH. However, questions regarding acute diagnosis, therapeutic decisions, and prognostication of ICH remain unanswered. Molecular biomarkers and imaging markers have revolutionalized diagnosis and treatment of many diseases, such as troponin use in myocardial infarction and magnetic resonance imaging (MRI) scan in ischemic stroke. Therefore, the investigators aim to discovery the potential biomarkers by screening samples of blood, cerebral spinal fluid, urine, saliva, and even tissues (if available) from ICH patients, and imaging markers via serial multimodality imaging scans such as computed tomography(CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), positron emission tomography (PET), etc. These molecular and imaging markers would assist in contributing additional information to current tools for onset warning, diagnosis, therapy monitoring, risk stratification, intervention and prognosis for ICH patients.

Key facts

Study ID

NCT06462274

Run by

Southwest Hospital, China

People needed

200

Starts

2014-01-01

Expected to finish

2026-12-01

Last updated by the study team

2024-06-17

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Individuals aged 18-80 years
• Hematoma size is more than 5 ml
• Evidence of a spontaneous ICH on CT scan
• Patient within 72 hours of ictus
• Glasgow Coma Scale (GCS) Score of 5-15.
• The history of hypertension

You may not qualify if…

• Individuals with age < 18 years or > 80 years
• Clear evidence that the hemorrhage is due to an aneurysm, arteriovenous malformation or other cerebrovascular diseases.
• ICH secondary to tumor or trauma..
• If the haematological effects of any previous anticoagulants are not completely reversed.
• Patients with heart insufficiency, lungs insufficiency, renal insufficiency, hepatic insufficiency, autoimmune diseases and other organ diseases with severe dysfunction.

Where it is running

• Department of Neurosurgery , Southwest Hospital, Third Military Medical University, — Chongqing, Chongqing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.